Abstract
BALB/cA mice were used to study the interaction of diabetes and meticillin-resistant Staphylococcus aureus (MRSA) infection on pathogen distribution, cytokine profile and inflammatory and endothelial-injury markers, as well as coagulation and anticoagulation factors. Meticillin-susceptible S. aureus (MSSA) infection did not cause death within the experimental period. MRSA-infected nondiabetic and diabetic mice died on 19.1+/-1.4 and 10.6+/-0.7 days post-infection (p.i.), respectively. MRSA and MSSA infection in diabetic mice did not result in symptomatic bacteraemia; however, MRSA infection in diabetic mice significantly reduced glucose levels (P<0.05). Diabetic mice showed significantly higher levels of C-reactive protein, fibrinogen, fibronectin and von Willebrand factor than nondiabetic mice (P<0.05), and MRSA infection further elevated the plasma levels of these inflammatory and endothelial markers (P<0.05). Before infection, diabetic mice had significantly higher plasminogen activator inhibitor-1 (PAI-1) activity, lower antithrombin III (AT-III) and protein C activities (P<0.05), and MRSA infection significantly increased PAI-1 activity further and reduced the activity of AT-III and protein C (P<0.05). MRSA infection incre...Continue Reading
References
Jul 1, 1991·Infection and Immunity·S N VogelR Neta
Jan 1, 1991·Immunology Letters·Y Endo
Apr 1, 1996·Journal of Autoimmunity·A ShimadaC G Fathman
Jul 1, 1997·The Journal of Antimicrobial Chemotherapy·K HiramatsuF C Tenover
Dec 17, 1997·Cellular Immunology·S T SmileyM J Grusby
Apr 3, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K J MattilaS Asikainen
Aug 26, 1998·The New England Journal of Medicine·F D Lowy
Jan 9, 1999·The New England Journal of Medicine·S BlotF Colardyn
Feb 20, 1999·Infection and Immunity·I M NilssonA Tarkowski
Jun 11, 1999·The American Journal of Physiology·T SakamotoS Fujii
Jul 23, 1999·Medical Hypotheses·M F McCarty
Mar 8, 2000·Diagnostic Microbiology and Infectious Disease·S C ChangC Y Liu
May 11, 2000·Seminars in Thrombosis and Hemostasis·T UranoA Takada
May 18, 2000·Scandinavian Cardiovascular Journal : SCJ·M Leinonen, P Saikku
Sep 2, 2000·Journal of Clinical Microbiology·R I JaffeD M Niemeyer
Sep 16, 2000·Journal of Diabetes and Its Complications·H AsakawaF Kawakami
Aug 10, 2001·Acta Tropica·S M GeigerH Schulz-Key
Aug 14, 2001·Atherosclerosis·M V CiarlaR Strom
Mar 13, 2002·Journal of Internal Medicine·V Mohamed-AliJ H Pinkney
May 10, 2002·Immunobiology·Andreas MüllerHelga Gleichmann
Jul 23, 2003·Diabetic Medicine : a Journal of the British Diabetic Association·K KainP J Grant
Sep 19, 2003·Pathophysiology of Haemostasis and Thrombosis·Irène Juhan-VagueMarie-Christine Alessi
Oct 4, 2003·Diabetes & Metabolism·M B GomesH J Matos
Oct 31, 2003·The Journal of Antimicrobial Chemotherapy·Shyh-ming TsaoMei-chin Yin
Dec 5, 2003·Medical Mycology·Angel GonzalezLuz E Cano
May 27, 2004·Diabetes Care·Yoshimasa AsoToshihiko Inukai
Sep 25, 2004·Experimental Biology and Medicine·Michiyo TomitaThomas J Santoro
Citations
Apr 1, 2010·Indian Journal of Clinical Biochemistry : IJCB·M BokaeianAzim Akbarzadeh
Jun 22, 2007·Critical Care Medicine·Kemal AgbahtJordi Rello
Apr 5, 2019·The Journal of Toxicological Sciences·Nana LongMin Dai
May 19, 2007·Journal of Medical Microbiology·Shih-Ming TsaoMei-Chin Yin
May 21, 2016·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Hong HeHai-Ying Gu
May 26, 2017·Frontiers in Cellular and Infection Microbiology·Markus BischoffRosmarie Gaupp
Feb 8, 2007·Journal of Clinical Apheresis·Christine M CsertiLynne Uhl